ImmuCell Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net income was USD 0.735666 million compared to net loss of USD 0.441303 million a year ago. Basic earnings per share from continuing operations was USD 0.1 compared to basic loss per share from continuing operations of USD 0.06 a year ago. Diluted earnings per share from continuing operations was USD 0.09 compared to diluted loss per share from continuing operations of USD 0.06 a year ago.